欧美文化:Omicron BA2 subvariant spreading as EU countries lift COVID-19 restrictions: EMA
2022-03-18来源:Xinhuanet
BRUSSELS, March 17 (Xinhua) -- Cases of Omicron BA2, a COVID-19 subvariant, are rising across the European Union (EU), the European Medicines Agency (EMA) said on Thursday.
"While many EU countries are lifting restrictions, we notice that the infection rates are increasing again in some member states, partly because of the circulation of Omicron BA2, which seems to be more transmissible than other variants," Marco Cavalieri, head of the EMA's strategy on biological health threats and vaccines, told journalists here.
What matters the most, he said, is how this increase in cases will stress the healthcare systems.
The EMA called non-vaccinated citizens to get jabbed as soon as possible, emphasizing that there are now five COVID-19 vaccines authorized in the EU using different technologies.
"There is currently no evidence that immune response after vaccination is significantly different with Omicron BA2. Vaccines continue to offer high protection against hospitalization and death," he said.
The vaccines that have received conditional marketing authorization from the EMA are those produced by Pfizer/BioNtech, Moderna, AstraZeneca, Janssen and Novavax.
"While many EU countries are lifting restrictions, we notice that the infection rates are increasing again in some member states, partly because of the circulation of Omicron BA2, which seems to be more transmissible than other variants," Marco Cavalieri, head of the EMA's strategy on biological health threats and vaccines, told journalists here.
What matters the most, he said, is how this increase in cases will stress the healthcare systems.
The EMA called non-vaccinated citizens to get jabbed as soon as possible, emphasizing that there are now five COVID-19 vaccines authorized in the EU using different technologies.
"There is currently no evidence that immune response after vaccination is significantly different with Omicron BA2. Vaccines continue to offer high protection against hospitalization and death," he said.
The vaccines that have received conditional marketing authorization from the EMA are those produced by Pfizer/BioNtech, Moderna, AstraZeneca, Janssen and Novavax.
相关文章
- 欧美文化:Feature: Kenyan rural women broaden revenue streams through basket weaving
- 欧美文化:At least 8 killed in Havana hotel explosion
- 欧美文化:U.S. FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk
- 欧美文化:Nearly 15 mln deaths directly or indirectly linked to COVID-19: WHO
- 欧美文化:U.S. secretary of state tests positive for COVID-19
- 欧美文化:Hungary "can't support" EU's new sanctions against Russia in current form:
- 欧美文化:Oil prices jump as EU aims for Russian oil ban
- 欧美文化:Ukraine gets 4.5 bln euros in int'l aid since start of conflict
- 欧美文化:At least 16 killed in bus-fuel truck collision in Ukraine
- 欧美文化:U.S. Fed on track for half-point rate hike as recession fears grow